
Profitability, historical returns, and peer comparisons.
According to Autolus Therapeutics plc’s latest financial reports and current stock price. The company's current ROE is -178.58%. This represents a change of 259.86% compared to the average of -49.62% of the last 4 quarters.
The mean historical ROE of Autolus Therapeutics plc over the last ten years is -68.17%. The current -178.58% ROE has changed 161.96% with respect to the historical average. Over the past ten years (40 quarters), AUTL's ROE was at its highest in in the December 2016 quarter at 0%. The ROE was at its lowest in in the December 2023 quarter at -69.23%.
Average
-68.17%
Median
-49.22%
Minimum
-186.93%
Maximum
-13.83%
Discovering the peaks and valleys of Autolus Therapeutics plc ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 275.12%
Maximum Annual ROE = -13.83%
Minimum Annual Increase = -72.38%
Minimum Annual ROE = -186.93%
| Year | ROE | Change |
|---|---|---|
| 2025 | -161.79% | 213.32% |
| 2024 | -51.64% | -72.38% |
| 2023 | -186.93% | 275.12% |
| 2022 | -49.83% | 9.88% |
| 2021 | -45.35% | -32.96% |
| 2020 | -67.65% | 39.21% |
| 2019 | -48.60% | 220.42% |
| 2018 | -15.17% | 9.64% |
| 2017 | -13.83% | -66.17% |
| 2016 | -40.90% | 13.46% |
The current ROE of Autolus Therapeutics plc (AUTL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-133.45%
5-year avg
-99.11%
10-year avg
-68.17%
Autolus Therapeutics plc’s ROE is greater than Lyell Immunopharma, Inc. (-107.62%), greater than Legend Biotech Corporation (-8.70%), less than Atara Biotherapeutics, Inc. (44.67%), greater than Caribou Biosciences, Inc. (-89.11%), greater than Precision BioSciences, Inc. (-58.09%), greater than Allogene Therapeutics, Inc. (-50.04%), greater than Cellectis S.A. (-94.14%), greater than Century Therapeutics, Inc. (-52.76%), greater than Fate Therapeutics, Inc. (-65.08%), greater than Mustang Bio, Inc. (-34.23%),
| Company | ROE | Market cap |
|---|---|---|
| -107.62% | $378.11M | |
| -8.70% | $4.21B | |
| 44.67% | $84.02M | |
| -89.11% | $47.64M | |
| -58.09% | $224.12M | |
| -50.04% | $411.13M | |
| -94.14% | $117.86M | |
| -52.76% | $302.40M | |
| -65.08% | $243.61M | |
| -34.23% | $2.79M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Autolus Therapeutics plc using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Autolus Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Autolus Therapeutics plc's ROE?
How is the ROE calculated for Autolus Therapeutics plc (AUTL)?
What is the highest ROE for Autolus Therapeutics plc (AUTL)?
What is the 3-year average ROE for Autolus Therapeutics plc (AUTL)?
What is the 5-year average ROE for Autolus Therapeutics plc (AUTL)?
How does the current ROE for Autolus Therapeutics plc (AUTL) compare to its historical average?